SynthesisThe Psychiatric quarterly2022

Adverse Effects of Esketamine for the Treatment of Major Depression Disorder: Findings from Randomized Controlled Trials.

Siyuan Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.